Companies / Materials
AVY
Avery Dennison
Paper & Plastic Packaging Products & Materials
Paper & Plastic Packaging Products & MaterialsAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health53
Growth26
Profitability38
Cash generation59
Balance sheet41
Dilution control100
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)5.2%Revenue growth (FY)1.1%Revenue CAGR (3y)-0.7%Gross margin28.8%Operating margin—Net margin7.8%Free cash flow margin8.0%R&D / revenue1.5%Stock comp / revenue0.3%Net debt / operating cash flow3.40xCurrent ratio1.13Diluted share count change-3.0%
| Fiscal year ending | FY 2022-01 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $8.4B | $9.0B | $8.4B | $8.8B | $8.9B |
| Gross profit | $2.3B | $2.4B | $2.3B | $2.5B | $2.5B |
| Net income | $740M | $757M | $503M | $705M | $688M |
| Operating cash flow | $1.0B | $961M | $826M | $939M | $881M |
| Capital expenditure | $255M | $278M | $265M | $209M | $169M |
| Free cash flow | $792M | $683M | $561M | $730M | $712M |
| R&D | $137M | $136M | $136M | $138M | $137M |
| Stock-based comp | $37M | $47M | $22M | $29M | $28M |
| Buybacks | $181M | $380M | $138M | $248M | $572M |
| Dividends | $221M | $239M | $257M | $278M | $288M |
| Cash | $163M | $167M | $215M | $329M | $203M |
| Total debt | $2.8B | $2.5B | $2.6B | $2.6B | $3.2B |
| Equity | $1.9B | $2.0B | $2.1B | $2.3B | $2.2B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.